Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 31,328 shares at $7.94 ($249K) on 2025-03-06, disclosed to the SEC on 2025-03-06.
Scheduled sale ($249k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.94 | 15,664 | $124K | 50.0% |
| 2 | $7.94 | 15,664 | $124K | 50.0% |
| Total | $7.94 avg | 31,328 | $249K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2023-03-29 | $20K | — | Filing → |